ACE I/D gene polymorphism: Presence of the ACE D allele increases the risk of coronary artery disease in younger individuals

Atherosclerosis

Volumn 139, Issue 1, 1998, Pages 153-159

  Gardemann, Andreas ^a   Fink, Monika ^a   Stricker, Jürgen ^a   Nguyen, Quoc D ^a   Humme, Jörg ^a   Katz, Norbert ^a   Tillmanns, Harald ^b   Hehrlein, Friedrich Wilhelm ^c   Rau, Matthias ^d   Haberbosch, Werner ^d  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c Klin fur Herz und G   (Germany)

^d KERCKHOFF HEART CENTER   (Germany)

Author keywords

ACE I D gene polymorphism; Cardiovascular diseases; Gensini score; Myocardial infarction; Renin angiotensin aldosteron system; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRINOGEN; LIPOPROTEIN A; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

ADULT; AGED; AGING; ALLELES; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0032127007     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00040-9     Document Type: Article

References (48)

1. Powell J.S., Clozel J.P., Muller R.K.M., Kuhn H., Hefti F., Hosang M., Baumgartner H.R. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 245:1989;186-188.
2. Chobanian A.V., Haudenschild C.C., Nickerson C., Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 15:1990;327-331.
3. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cyomolgus monkeys. Cardiovasc Pharmacol 1990;15(Suppl 15):S65-S72.
4. Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990;15:68-77.
5. The SOLVD investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med. 325:1991;293-302.
6. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J., Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C., Klein M., Lamas G.A., Packer M., Rouleau J., Rouleau J.L., Rutherford J., Wertheimer J.H. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med. 327:1992;669-677.
7. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
8. Ambrosioni E., Bacchelli S., Degli Esposti D., Borghi C. ACE-inhibitors and atherosclerosis. Eur J Epidemiol. 8(Suppl 2):1992;129-133.
9. Pelc L.R., Gross G.J., Warltier D.C. Mechanism of coronary vasodilation produced by bradykinin. Circulation. 83:1991;2018-2056.
10. Wiemer G., Scholkens B.A., Becker R.H., Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 18:1991;558-563.
11. Campbell-Boswell M., Robertson A.L. Effects of angiotensin II and vasopressin on human smooth muscle in vitro. Exp Mol Pathol. 35:1981;265-267.
12. Naftilan A.J., Pratt R.E., Dzau V.J. Induction of platelet-derived growth factor A chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1419-1424.
13. Kawahara Y., Sunako M., Tsuda T., Fukuzaki H., Fukumoto Y., Takai Y. Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 150:1988;52-59.
14. Fernandez L.A., Twickler J., Mead A. Neovascularization produced by angiotensin II. Lab Clin Med. 105:1985;141-145.
15. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
16. Gardemann A., Schwartz O., Weiß T., Katz N., Eberbach A., Hehrlein W., Tillmanns G., Waas W., Haberbosch W. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated to coronary artery disease and myocardial infarction in low risk patients. Circulation. 92:1995;2796-2799.
17. Singer D.R.J., Missouris C.G., Jeffery S. Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion? Circulation. 94:1996;236-239.
18. Samani N.J., Thompson J.R., O'Toole L., Channer K., Woods K.L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme with myocardial infarction. Circulation. 94:1996;708-712.
19. Kurtz T.W. The ACE of hearts. Nature. 359:1992;588-589.
20. Mattu R.K., Needham E.W.A., Galton D.J., Frangos E., Clark A.J.L., Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly heart study. Circulation. 91:1995;270-274.
21. Nakai K., Itoh C., Miura Y., Hotta K., Musha T., Itoh T., Miyakawa T., Iwasaki R., Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 90:1994;2199-2202.
22. Sigusch H.H., Vogt S., Gruber U., Reinhardt D., Lang K., Surber R., Farker K., Muller S., Hoffmann A. Angiotensin I converting enzyme DD genotype is a risk factor of coronary artery disease. Scand J Clin Lab Invest. 57:1997;127-132.
23. Ruiz J., Blanche H., Cohen N., Velho G., Cambien F., Cohen D., Passa P., Froguel P. Insertion/deletion polymorphism of the angiotensin converting enzyme gene is strongly associated with coronary heart disease in subjects in non insulin dependent diabetes mellitus. Proc Natl Acad Sci USA. 91:1994;3662-3665.
24. Ludwig E.H., Comeli P.S., Anderson J.L., Marshall H.W., Lalouel J.M., Ward R.H. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 91:1995;2120-2124.
25. Cambien F., Costerousse O., Tiret L., Poirier O., Lecerf L., Gonzales M.F., Evans A., Arweiler D., Cambou J.P., Luc G., Rakotovao R., Ducimetiere P., Soubrier F., Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 90:1994;669-674.
26. Friedl W., Krempler F., Paulweber B., Pichler M., Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary artery disease in an Austrian population. Atherosclerosis. 112:1995;137-143.
27. Tokgozoglu S.L., Alikasifoglu M., Atalar E., Tuncbilek E., Ovunc K., Aksoyek S., Kabakci G., Anar B., Unsal I., Kes S. Angiotensin converting enzyme gene polymorphism and the risk and extent of ischemic heart disease among Turkish patients. Coron Artery Dis. 8:1997;137-141.
28. Chang F.T., Lai Z.P., Chern T.H., Tseng C.D., Hsu K.L., Lo H.M., Tseng Y.Z. Lack of association between angiotensin converting enzyme gene polymorphism and coronary heart disease in a Chinese population. Jpn Heart J. 38:1997;227-236.
29. Saha N., Talmud P.J., Tay J.S.H., Humphries S.E., Basair J. Lack of association of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism with CAD in two Asian populations. Clin Genet. 50:1996;121-125.
30. Lindpaintner K., Pfeffer M.A., Kreutz R., Stampfer M., Grodstein F., La Motte F., Buring J., Hennekens C.H. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 332:1995;706-711.
31. Agerholm-Larsen B., Nordestgaard B.G., Steffensen R., Sorensen T.I.A., Jensen G., Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10 150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation. 95:1997;2358-2367.
32. Ramasamy R., Manra J.M., Kotea N., Shun N.K., Genin E., Feingold J., Krishnamoorthy R., Baligadoo S. Lack of association of angiotensin I converting enzyme gene polymorphism and premature myocardial infarction in Mauritian Indians. Clin Genet. 50:1996;551-554.
33. Bohn M., Berge K.E., Bakken A., Erikssen J., Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I converting enzyme and myocardial infarction. Clin Genet. 44:1993;292-297.
34. Gensini GG. Coronary arteriography. In: Braunwald E, editor. Heart Disease. Philadelphia: WB Saunders, 1980:352-353.
35. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 51:1983;606.
36. Fossati P., Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 82:1982;2077-2080.
37. Kattermann R., Jaworek D., Moller G., Assmann G., Bjorkhem I., Svensson L., Borner K., Boerma G., Leijnse B., Desager J.P. Multicenter study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem. 22:1984;245-251.
38. Fink P.C., Romer M., Haeckel R., Fateh-Moghadam A., Delanghe J., Gressner A.M., Dubs R.W. Measurement of proteins with the Behring nephelometer. A multicenter evaluation. J Clin Chem Clin Biochem. 27:1989;261.
39. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol (Basel). 17:1957;237.
40. Kawasaki ES. Sample preparation from blood, cells, and other fluids. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols: A Guide to Methods and Applications. San Diego: Academic Press, 1990:146-152.
41. Raynolds M.V., Bristow M.R., Bush E.W., Abraham W., Lowes B.D., Zisman L.S., Taft C.S., Perryman M.B. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet. 342:1993;1073-1075.
42. Evans A.E., Poirier O., Kee F., Lecerf L., McCrum E., Falconer T., Crane J., O'Rourke D.F., Cambien F. Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q J Med. 87:1994;211-214.
43. Tiret L., Rigat B., Poirier O., Nicaud V., Lecerf L., Evans A., Cambou J.-P., Arveiler D., Luc G., Amouyel P. Deletion polymorphism in the angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 341:1993;991-992.
44. Bohn M., Berge K.E., Bakken A., Erikssen J., Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet. 44:1993;298-301.
45. Badenhop R.F., Wang X.L., Wilcken D.E.L. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation. 91:1995;1655-1658.
46. Steering Committee of the Physicians Health Study Research Group Final report on the aspirin component of the ongoing Physicians Health Study. N Engl J Med. 321:1989;129-135.
47. Ohishi M., Rakugi H., Higaki J., Miki T., Ogihara T. Angiotensin-converting enzyme genotype and ischemic heart disease. N Engl J Med. 333:1995;459.
48. Meyer B.R., Vashishtha A. Angiotensin-converting enzyme genotype and ischemic heart disease. N Engl J Med. 333:1995;458-459.